Entain Foundation donates £ 100,000 to fight pandemic in India

 The World Health Organization (WHO) reports that nearly half of all new Covid-19 cases in the world occurred in India last week.

Currently the number of new infections reaches 500,000 a day, which has generated a crisis in Indian hospitals that are experiencing a chronic lack of oxygen and other key medical supplies.

It should be noted that Entain’s donation will enable Crown Agents to supply 25 Invacare Platinum Oxygen concentrators, as well as the drugs Remdesivir, Tocilizumab and Dexamethasone, used in the treatment of the virus. The combination of the oxygen concentrators and medical supplies will allow for the treatment of more Covid-19 patients in their own homes, in turn reducing some of the strain on India’s medical infrastructure.

This important donation is another sign of Entain's strong social commitment in the communities where it operates, we recall that the company employs more than 2,500 people in India through its IvyTech subsidiary in Hyderabad.

The Group is making extensive efforts in support of its Indian-based colleagues and their families on the ground, including the procurement of critical medicines, emergency hospitalization support, assistance with medical insurance and online medical consultations.

Commenting on the donation, Entain CEO Jette Nygaard-Andersen said: “We stand shoulder-to-shoulder with our colleagues and the Indian people at large in what is a hugely challenging time for all. We hope that the supply of oxygen concentrators and Covid-19 drugs will make a contribution to helping in the fight against this dreadful virus”.

On the other hand, Fergus Drake, CEO of Crown Agents, appreciates the great support of Entain and said: “We are deeply concerned about the current situation in India. Especially in these difficult times, we must stand together to beat the virus globally, once and for all".